Introduction: what is preeclampsia and why ask when it was discovered?
Preeclampsia is a pregnancy complication characterized by new-onset high blood pressure and often protein in the urine after 20 weeks of gestation. It can escalate to severe features, posing risks to both birthing person and baby. The question when was preeclampsia discovered points to layered answers: ancient descriptions of swelling and seizures, 17th century codifications of hypertensive disorders in pregnancy, and later biomedical clarification in the 19th and 20th centuries. Understanding this history helps contextual现代 diagnosis, underscores persistent gaps in care, and highlights how definitions and criteria evolved as clinical science advanced.
Early historical mentions: descriptions long before the term preeclampsia
Evidence suggests that severe elevations in blood pressure and convulsions in pregnancy were recognized in diverse medical traditions long before the word preeclampsia appeared. Hippocratic texts from ancient Greece and descriptions in Sanskrit medical writings note convulsive illness and edema in pregnancy. In the 17th century, English physician William Harvey and others documented pregnancy-related hypertension with more systematic detail. These early accounts lacked a unified name or diagnostic criteria, but they indicate that clinicians observed dangerous hypertensive syndromes long before modern classification. The roots are therefore ancient and multinational, with scattered case descriptions rather than a single discovery moment.
Pre-1900 references to pregnancy-related convulsions and high blood pressure
- Hippocratic corpus (c. 400 BCE): mentions convulsions and edema in pregnancy.
- Susruta Samhita (c. 600 BCE, translated centuries later): describes swelling and complications in pregnancy.
- William Harvey, Exercitationes de Decubitu et Curatione Efficaciorus (1650): notes dropsical swellings and circulatory changes in pregnant patients.
Early 1900s: naming and first formal descriptions
By the late 19th and early 20th centuries, clinicians began to define a specific syndrome of blood pressure elevation, edema, and proteinuria in pregnancy. The term preeclampsia emerged to distinguish this condition from chronic hypertension and other kidney diseases. Key milestones include clearer descriptions of postpartum onset and recognition that symptoms could occur days to weeks after delivery. Definitions remained variable, but systematic record-keeping in obstetric units improved the ability to track incidence and outcomes. These advances laid groundwork for later diagnostic criteria and research into causes and prevention.
Landmark early-20th century observations
- 1914: Janney describes albuminuria and hypertension in pregnancy as an obstetric entity. p>1920s: Multiple clinicians use the term toxemia of pregnancy, reflecting theories about toxins, though this mechanism-focused label later gave way to syndrome-based criteria.
- 1930s: Studies start to link severe features such as visual changes, headache, and rising blood pressure to poor outcomes, prompting earlier intervention.
1970s–1990s: standardization and the ISSHP classification
A major shift came when experts sought consistent criteria for research and clinical care. In 1977, the International Society for the Study of Hypertension in Pregnancy (ISSHP) proposed standardized definitions, distinguishing gestational hypertension from preeclampsia based on proteinuria and timing. Subsequent revisions emphasized blood pressure thresholds and the importance of severe features, such as systolic blood pressure ≥160 mmHg or diastolic ≥110 mmHg, thrombocytopenia, impaired liver function, renal insufficiency, and cerebral or visual symptoms. These criteria enabled more accurate epidemiological studies and clearer communication among providers.
| Date or Period | Event | Why it matters |
|---|---|---|
| 1977 | ISSHP proposes formal diagnostic criteria for hypertensive disorders of pregnancy. | Enables consistent classification, research comparisons, and care guidelines. |
| 1990s | Recognition of postpartum preeclampsia and late-onset disease. | Expands awareness that severe features can occur after delivery. |
| 2013 | ACOG and ISSHP refine definitions; emphasize blood pressure ≥140/90 mmHg plus organ involvement. | Broadens detection to include moderate-range blood pressures with significant features. |
Late 20th century to present: pathophysiology, biomarkers, and modern criteria
By the late 20th century, research began to clarify that preeclampsia involves abnormal placental development, endothelial dysfunction, inflammation, and sometimes HELLP syndrome or eclampsia. The role of biomarkers such as serum uric acid and later placental growth factor testing entered investigation, though clinical use remains context-dependent. In 2013, ACOG and ISSHP updated definitions to require blood pressure ≥140/90 mmHg with new-onset proteinuria or signs of maternal organ involvement, shifting focus from proteinuria thresholds alone. Later guidelines (e.g., 2019 ACOG) emphasized that severe features can prompt urgent management even without proteinuria. These refinements aim to improve early recognition and reduce severe maternal morbidity and mortality.
2010s criteria and clinical implications
Current criteria categorize preeclampsia as either early-onset (before 34 weeks, often with severe features and placental insufficiency) or late-onset (at or beyond 34 weeks). The emphasis is on syndrome components: blood pressure thresholds, end-organ dysfunction, and, in some classifications, biomarkers. This framework supports shared decision-making and timely delivery when risks outweigh continuing the pregnancy. Postpartum monitoring remains essential because severe features can first appear or worsen after birth.
Key takeaways on the discovery timeline
No single date marks the discovery of preeclampsia. Instead, knowledge accumulated across eras and regions, with ancient texts noting severe pregnancy complications, early modern clinicians linking hypertension and edema to obstetric risk, and 20th century standardization enabling consistent diagnosis and research. Understanding this timeline underscores that recognition is ongoing, and modern definitions continue to evolve as evidence about pathophysiology and outcomes grows. Careful monitoring, timely blood pressure measurement, and awareness of both antepartum and postpartum risk remain central to reducing harm.
Frequently asked questions
- What are the historical names for preeclampsia? Historically, clinicians used terms such as toxemia of pregnancy and pregnancy-induced hypertension. These labels reflected theories of the time and have largely been replaced by preeclampsia and gestational hypertension based on clinical findings and timing.
- How has the definition of preeclampsia changed over time? Earlier criteria emphasized proteinuria thresholds; current guidelines highlight blood pressure ≥140/90 mmHg plus signs of maternal organ involvement or placental dysfunction, broadening detection and enabling earlier intervention.
- Why does the timeline of discovery matter for care today? Recognizing the historical evolution illustrates why definitions remain pragmatic and evolving; it reinforces the need for vigilance across the antepartum and postpartum periods and supports guideline updates that improve outcomes.
Conclusion
The discovery and understanding of preeclampsia unfolded over centuries, from fragmented early observations to standardized criteria and ongoing research into causes and prevention. Key milestones include early descriptive reports, the introduction of standardized definitions in the 1970s, and iterative refinements in the 2010s that emphasize blood pressure thresholds and organ involvement. This history highlights both progress and gaps, reinforcing that timely detection, careful monitoring, and guideline-informed care remain essential for reducing risks to birthing people and babies.